LEADER 02928nam  2200577Ia 450 
001 9910143224603321
005 20170815115823.0
010   $a1-280-36674-5
010   $a9786610366743
010   $a0-471-46132-6
010   $a0-471-22483-9
035   $a(CKB)111087027113122
035   $a(EBL)157062
035   $a(OCoLC)475872569
035   $a(SSID)ssj0000166552
035   $a(PQKBManifestationID)11154442
035   $a(PQKBTitleCode)TC0000166552
035   $a(PQKBWorkID)10161422
035   $a(PQKB)11353828
035   $a(MiAaPQ)EBC157062
035   $a(EXLCZ)99111087027113122
100   $a20011031d2002      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aGuiding Icarus$b[electronic resource] $emerging bioethics with corporate interests /$fRahul K. Dhanda ; foreword by Philip R. Reilly
210   $aNew York $cJohn Wiley & Sons$dc2002
215   $a1 online resource (298 p.)
300   $aDescription based upon print version of record.
311   $a0-471-22380-8 
320   $aIncludes bibliographical references (p. 258-260) and index.
327   $aGUIDING ICARUS; CONTENTS; Foreword; Preface; Acknowledgments; 1 Introduction; 2 Genetically Modified Foods; I. Executive Summary; II. The Science; III. The Benefits; IV. The Issues; V. Industry; VI. Recommendations; 3 DNA Data Banking; I. Executive Summary; II. The Science; III. The Benefits; IV. The Issues; V. Industry; VI. Recommendations; 4 Personalized Medicine; I. Executive Summary; II. The Science; III. The Benefits; IV. The Issues; V. Industry; VI. Recommendations; 5 Stem Cells; I. Executive Summary; II. The Science; III. The Benefits; IV. The Issues; V. Industry; VI. Recommendations
327   $a6 ConclusionGlossary; Suggested Reading; Index
330   $a""There is a palpable need for business to explore the issues Dhanda raises. Guiding Icarus offers a flight plan.""-from the Foreword by Philip R. Reilly While bioethicists may enjoy the most thorough appreciation of both the promise and perils of new biotechnologies, international corporations are in fact the entities generating these technologies and determining their application. An industry insider versed in the language of bioethics, Rahul Dhanda offers in Guiding Icarus: Merging Bioethics with Corporate Interests a Rosetta stone to these two camps, explaining why each
606   $aBiotechnology industries
606   $aBiotechnology$xMoral and ethical aspects
608   $aElectronic books.
615  0$aBiotechnology industries.
615  0$aBiotechnology$xMoral and ethical aspects.
676   $a174.957
676   $a174/.96606
700   $aDhanda$b Rahul K$0921822
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910143224603321
996   $aGuiding Icarus$92068280
997   $aUNINA